Profil
Willem M.
de Vos has founded MicroDish BV in 2008, A-Mansia Biotech SA (Belgium) in 2016, and Alba Health ApS Filial in 2022.
Mr. de Vos is also the founder of Caelus Pharmaceuticals BV.
Aktive Positionen von Willem de Vos
| Unternehmen | Position | Beginn |
|---|---|---|
MicroDish BV
MicroDish BV Miscellaneous Commercial ServicesCommercial Services Manufactures miniature culture chip technology platforms | Gründer | 01.01.2008 |
Ehemalige bekannte Positionen von Willem de Vos
| Unternehmen | Position | Ende |
|---|---|---|
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Gründer | - |
Alba Health ApS Filial
Alba Health ApS Filial Miscellaneous Commercial ServicesCommercial Services Provides digital gut health support to children based on AI and gut microbiome testing | Gründer | - |
Caelus Pharmaceuticals BV
Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops treatments for cardiometabolic diseases based on improving intestinal microbial composition | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
MicroDish BV
MicroDish BV Miscellaneous Commercial ServicesCommercial Services Manufactures miniature culture chip technology platforms | Commercial Services |
Caelus Pharmaceuticals BV
Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops treatments for cardiometabolic diseases based on improving intestinal microbial composition | Health Technology |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Health Technology |
Alba Health ApS Filial
Alba Health ApS Filial Miscellaneous Commercial ServicesCommercial Services Provides digital gut health support to children based on AI and gut microbiome testing | Commercial Services |
















